Defects in insulin secretion, insulin action or both leads to the metabolic disorder called diabetes mellitus. It increases the risk for many serious health problems and the development of diabetes mellitus leads to specific pathology occurs in retina, renal glomerulus and peripheral nerve. So, the goals of treatment are to prevent complications and organ damages. The therapeutic approach to reduce the postprandial rise in blood glucose level can be achieved by the inhibition of α-amylase and α-glucosidase involved in the carbohydrate digestion process. Herbal treatment is considered as very safe and less side effects when compare to synthetic drugs. Hence, the present study deals with evaluation of in vitro antidiabetic activity of aqueous seed extract of C.tetragonoloba (L). The aqueous seed extract was delved into α-amylase and α-glucosidase inhibitory assay for their anti-hyperglycemic potential. IC₅₀ value for α-amylase and α-glucosidase inhibition were found to be 244.57μg/ml and 205.66μg/ml respectively. The results revealed that the aqueous seed extract possesses significant inhibitory action on both α-amylase and α-glucosidase in a dose dependent manner as compared to control.  Due to the presence of flavonoids, saponins and tannins in this extract may exhibit this inhibitory activity. Hence, this report suggests that it can be an effective lead compound against diabetes.

1.          World Health Organization (WHO). Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva: International Diabetes Federation: WHO; 2006.

2.          The Hindu, Huge increase in cases of diabetes in rural T.N. Hindu. 2020 [Feb 26 Wednesday].

3.         Melinda A. Non-insulin dependent diabetes mellitus treatment with sulphonylureas in Clinical Endocrinology and metabolism. N Engl J Med. 1988:443-53. doi: 10.1016/s0950-351x(88)80042-9.

4.        Kamiyama O, Sanae F, Ikeda K, Higashi Y, Minami Y, Asano N, Adachi I, Kato A. In vitro inhibition of α-glucosidases and glycogen phosphorylase by catechin gallates in green tea. Food Chem. 2010 Oct 15;122(4):1061-6. doi: 10.1016/j.foodchem.2010.03.075.

5.          Li YQ, Zhou FC, Gao F, Bian JS, Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase. J Agric Food Chem. 2009 Dec 23;57(24):11463-8. doi: 10.1021/jf903083h, PMID 19938837.

6.          McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J Agric Food Chem. 2005 Apr 6;53(7):2760-6. doi: 10.1021/jf0489926, PMID 15796622.

7.      Jung M, Park M, Lee HC, Kang YH, Kang ES, Kim SK. Antidiabetic agents from medicinal plants. Curr Med Chem. 2006 Apr 1;13(10):1203-18. doi: 10.2174/092986706776360860, PMID 16719780.

8.     Notkins AL. Immunologic and genetic factors in type 1 diabetes. J Biol Chem. 2002 Nov 15;277(46):43545-8. doi: 10.1074/jbc.R200012200, PMID 12270944.

9.         Sultan M, Zakir N, Rabbani MA, Shinwari ZA, Masood MS. Genetic diversity of guar (Cyamopsis tetragonoloba L.) Landraces from Pakistan based on RAPD markers. Pak J Bot. 2013 May 1;45(3):865-70. Available form: https://www.pakbs.org/pjbot/PDFs/45(3)/19.pdf

10.          Hamdan II, Afifi FU. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J Ethnopharmacol. 2004 Jul 1;93(1):117-21. doi: 10.1016/j.jep.2004.03.033, PMID 15182916.

11.     Sun Z, Henson CA. Extraction of α?glucosidase from Germinated Barley Kernels. J Inst Brew. 1992 Jul 8;98(4):289-92. doi: 10.1002/j.2050-0416.1992.tb01110.x.

12.  Kandra L. α-amylases of medical and industrial importance. J Mol Struct. 2003 Dec 1;666-667:487-98. doi: 10.1016/j.theochem.2003.08.073.

13.    Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005 Jan 18;172(2):213-26. doi: 10.1503/cmaj.1031414, PMID 15655244.

14.      Gawade B, Farooqui M. Alpha-amylase inhibitory assay of Argemone mexicana L. Leaves. J Chem Pharm Res. 2017;9(12):25-9. Available from: https://www.jocpr.com/articles/alphaamylase-inhibitory-assay-of-argemone-mexicana-l-leaves.pdf

15.   Vanderpump M, Bailey CJ. Book Review: Type 2 diabetes in practice. J R Soc Med. 2001 Aug;94(8):422-3. doi: 10.1177/014107680109400818.

16.         Tamilselvi K, Ananad SP, Doss A. Evaluation of in-vitro antidiabetic activity of Gardenia latifolia Ait. Int J Health Sci Res. 2018;8(8):226-30. Available from: https://www.ijhsr.org/IJHSR_Vol.8_Issue.8_Aug2018/34.pdf